beta
/Nuance Medical Launches HurriCaine ONE® Lidocaine at APIC 2026
NEWS

Nuance Medical Launches HurriCaine ONE® Lidocaine at APIC 2026

PRNewswire
2026/06/11New Products & Services
Nuance Medical Launches HurriCaine ONE® Lidocaine at APIC 2026 News provided by Nuance Medical Jun 11, 2026, 13:00 ET Share this article Share to X Share this article Share to X New Unit-Dose Lidocaine Formulation Pairs Rapid Topical Anesthesia with Infection Control Built for Today's Clinical Environments NASHVILLE, Tenn. , June 11, 2026 /PRNewswire/ -- Nuance Medical , a leader in innovative topical anesthetics, today announced the launch of HurriCaine ONE Lidocaine , a new, unit-dose topical anesthetic designed to deliver fast pain relief while strengthening infection prevention protocols. The product makes its debut at the APIC 2026 Annual Conference & Expo , June 15-17, in Nashville, TN. Continue Reading HurriCaine ONE Lidocaine is a new, unit-dose topical anesthetic designed to deliver fast pain relief while strengthening infection prevention protocols. As healthcare facilities face ongoing challenges with infection prevention and seek efficient, single-use solutions, HurriCaine ONE Lidocaine offers a reliable, fast-acting solution for temporary pain relief. As healthcare facilities face ongoing challenges with infection prevention and seek efficient, single-use solutions, HurriCaine ONE Lidocaine offers a reliable, fast-acting solution for temporary pain relief. Built on the trusted HurriCaine brand, the new formulation provides: Infection Control by Design: Single-patient-use, unit-dose packaging significantly reduces the risk of cross-contamination compared to traditional multi-use creams or gels. Quality & Safety Assurance: Tested to introduce no additional bioburden and fully compliant with FDA requirements for antiseptic performance. CHG Compatibility: Fits seamlessly into existing skin preparation and infection prevention protocols. Rapid Onset: Delivers pain relief within 5 minutes. Non-Aerosol Spray: Allows practitioners to target the area easily and efficiently. Procedures: Venipuncture and blood draws Vaccinations IV starts, port access, PICC lines Minor external procedures (cuts, scrapes, burns) Pre‑injection pain management "Topical lidocaine shouldn't come at the cost of infection control. With HurriCaine ONE Lidocaine, it doesn't. We're proud to launch it at APIC," said Mark Steele, President, Nuance Medical. HurriCaine ONE Lidocaine is purpose-built for procedures that demand fast, targeted, and hygienic topical anesthesia. See It at APIC 2026 Visit Booth #2225 on the APIC Expo floor, June 15–17, for live demonstrations of HurriCaine ONE Lidocaine. For more information on Nuance Medical, visit: www.NuanceMedical.com/HurriCaineONE About Nuance Medical Nuance Medical is dedicated to delivering innovative, effective, and safe topical anesthetic solutions to the medical and dental communities. With a focus on patient comfort and infection control, we strive to be trusted partners in advancing patient care. SOURCE Nuance Medical 21 % more press release views with Request a Demo × Modal title
Summary

New Unit-Dose Lidocaine Formulation Pairs Rapid Topical Anesthesia with Infection Control Built for Today's Clinical Environments NASHVILLE, Tenn., June 11, 2026 /PRNewswire/ -- Nuance Medical, a leader in innovative topical anesthetics, today announced the launch of HurriCaine ONE...